Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lineage Cell Therapeutics (LCTX) Preferred Dividend Payments: 2014-2015

Historic Preferred Dividend Payments for Lineage Cell Therapeutics (LCTX) over the last 2 years, with Dec 2015 value amounting to -$415,000.

  • Lineage Cell Therapeutics' Preferred Dividend Payments fell 1666.04% to -$830,000 in Q4 2015 from the same period last year, while for Dec 2015 it was -$380,000, marking a year-over-year change of. This contributed to the annual value of -$415,000 for FY2015, which is 577.01% down from last year.
  • Lineage Cell Therapeutics' Preferred Dividend Payments amounted to -$415,000 in FY2015, which was down 577.01% from $87,000 recorded in FY2014.
  • Lineage Cell Therapeutics' 5-year Preferred Dividend Payments high stood at $87,000 for FY2014, and its period low was -$415,000 during FY2015.
  • For the 2-year period, Lineage Cell Therapeutics' Preferred Dividend Payments averaged around -$164,000, with its median value being -$164,000 (2014).
  • Data for Lineage Cell Therapeutics' Preferred Dividend Payments shows a maximum YoY tumbled of 577.01% (in 2015) over the last 5 years.
  • Yearly analysis of 2 years shows Lineage Cell Therapeutics' Preferred Dividend Payments stood at $87,000 in 2014, then crashed by 577.01% to -$415,000 in 2015.